Literature DB >> 15112229

Can flies help humans treat neurodegenerative diseases?

J Lawrence Marsh1, Leslie Michels Thompson.   

Abstract

Neurodegenerative diseases are becoming increasingly common as life expectancy increases. Recent years have seen tremendous progress in the identification of genes that cause these diseases. While mutations have been found and cellular processes defined that are altered in the disease state, the identification of treatments and cures has proven more elusive. The process of finding drugs and therapies to treat human diseases can be slow, expensive and frustrating. Can model organisms such as Drosophila speed the process of finding cures and treatments for human neurodegenerative diseases? We pose three questions, (1) can one mimic the essential features of human diseases in an organism like Drosophila, (2) can one cure a model organisms of human disease and (3) will these efforts accelerate the identification of useful therapies for testing in mice and ultimately humans? Here we focus on the use of Drosophila to identify potential treatments for neurodegenerative diseases such as Huntington's and we discuss how well these therapies translate into mammalian systems. Copyright 2004 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15112229     DOI: 10.1002/bies.20029

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  24 in total

Review 1.  Modifiers and mechanisms of multi-system polyglutamine neurodegenerative disorders: lessons from fly models.

Authors:  Moushami Mallik; Subhash C Lakhotia
Journal:  J Genet       Date:  2010-12       Impact factor: 1.166

Review 2.  All neuropathies great and small.

Authors:  Ellen B Penny; Brian D McCabe
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

3.  Identification of combinatorial drug regimens for treatment of Huntington's disease using Drosophila.

Authors:  Namita Agrawal; Judit Pallos; Natalia Slepko; Barbara L Apostol; Laszlo Bodai; Ling-Wen Chang; Ann-Shyn Chiang; Leslie Michels Thompson; J Lawrence Marsh
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-16       Impact factor: 11.205

Review 4.  The Tiny Drosophila Melanogaster for the Biggest Answers in Huntington's Disease.

Authors:  Abraham Rosas-Arellano; Argel Estrada-Mondragón; Ricardo Piña; Carola A Mantellero; Maite A Castro
Journal:  Int J Mol Sci       Date:  2018-08-14       Impact factor: 5.923

5.  Systematic genetic interaction studies identify histone demethylase Utx as potential target for ameliorating Huntington's disease.

Authors:  Wan Song; Nóra Zsindely; Anikó Faragó; J Lawrence Marsh; László Bodai
Journal:  Hum Mol Genet       Date:  2018-02-15       Impact factor: 6.150

6.  Palmitoyl-protein thioesterase 1 deficiency in Drosophila melanogaster causes accumulation of abnormal storage material and reduced life span.

Authors:  Anthony J Hickey; Heather L Chotkowski; Navjot Singh; Jeffrey G Ault; Christopher A Korey; Marcy E MacDonald; Robert L Glaser
Journal:  Genetics       Date:  2006-02-01       Impact factor: 4.562

7.  Suppression of Huntington's disease pathology in Drosophila by human single-chain Fv antibodies.

Authors:  William J Wolfgang; Todd W Miller; Jack M Webster; James S Huston; Leslie M Thompson; J Lawrence Marsh; Anne Messer
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-01       Impact factor: 11.205

Review 8.  Transgenic Drosophila models of Alzheimer's disease and tauopathies.

Authors:  Kanae Iijima-Ando; Koichi Iijima
Journal:  Brain Struct Funct       Date:  2009-12-05       Impact factor: 3.270

9.  Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease.

Authors:  Judit Pallos; Laszlo Bodai; Tamas Lukacsovich; Judith M Purcell; Joan S Steffan; Leslie Michels Thompson; J Lawrence Marsh
Journal:  Hum Mol Genet       Date:  2008-09-01       Impact factor: 6.150

10.  An arginine/lysine-rich motif is crucial for VCP/p97-mediated modulation of ataxin-3 fibrillogenesis.

Authors:  Annett Boeddrich; Sébastien Gaumer; Annette Haacke; Nikolay Tzvetkov; Mario Albrecht; Bernd O Evert; Eva C Müller; Rudi Lurz; Peter Breuer; Nancy Schugardt; Stephanie Plassmann; Kexiang Xu; John M Warrick; Jaana Suopanki; Ullrich Wüllner; Ronald Frank; Ulrich F Hartl; Nancy M Bonini; Erich E Wanker
Journal:  EMBO J       Date:  2006-03-09       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.